Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 0.4470
-0.0050 (-1.11%)
At close: Feb 4, 2026
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 188.44 million as of February 5, 2026. Its market cap has decreased by -43.05% in one year.
Market Cap
188.44M
Enterprise Value
171.64M
Revenue
3.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since April 30, 1999, Medivir AB's market cap has decreased from 643.11M to 188.44M, a decrease of -70.70%. That is a compound annual growth rate of -4.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 200.56M | 9.29% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Works Technologies AB | 283.36M |
| Elicera Therapeutics AB | 249.96M |
| Xintela AB | 242.88M |
| Magle Chemoswed Holding AB | 235.40M |
| AlzeCure Pharma AB | 228.68M |
| Xbrane Biopharma AB | 216.27M |
| Initiator Pharma | 201.25M |
| NextCell Pharma AB | 182.46M |